Romainville
France
15
2013-05-30
9
2014-05-06
These are the the leading inventors for applications assigned to Cellectis:
Cellectis based in Romainville, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
CELL PENETRATING PEPTIDE CONJUGATES FOR DELIVERING OF NUCLEIC ACIDS INTO A CELL
#2 | 2012-10-11 β Patent 8,715,992 granted on 2014-05-06I- meganuclease variants with modified specificity, method of preparation and uses thereof
#3 | 2011-10-27 β Patent 8,476,072 granted on 2013-07-02Meganuclease recombination system
#4 | 2011-09-15 β Patent 9,273,296 granted on 2016-03-01Meganuclease variants cleaving a DNA target sequence from a glutamine synthetase gene and uses thereof
#5 | 2011-08-23 β Patent 8,003,595 granted on 2011-08-23Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
#6 | 2011-06-30Heterodimeric Meganucleases and Use Thereof
#7 | 2011-03-24I-CREI MEGANUCLEASE VARIANTS WITH MODIFIED SPECIFICITY, METHOD OF PREPARATION AND USES THEREOF
#8 | 2010-12-23 β Patent 8,426,177 granted on 2013-04-23Meganuclease variants cleaving a DNA target sequence from the mouse ROSA26 locus and uses thereof
#9 | 2010-06-17HYBRID AND SINGLE CHAIN MEGANUCLEASES AND USE THEREOF
#10 | 2010-06-10MEGANUCLEASE VARIANTS CLEAVING A DNA TARGET SEQUENCE FROM THE HPRT GENE AND USES THEREOF
#11 | 2010-06-10 β Patent 7,842,489 granted on 2010-11-30Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
#12 | 2010-01-28 β Patent 7,897,372 granted on 2011-03-01I-I meganuclease variants with modified specificity, method of preparation and uses thereof
#13 | 2009-09-03MEGANUCLEASE VARIANTS CLEAVING A DNA TARGET SEQUENCE FROM A XERODERMA PIGMENTOSUM GENE AND USES THEREOF
#14 | 2008-10-30 β Patent 8,211,685 granted on 2012-07-03I-I derivatives with enhanced activity at 37Β° C and use thereof
#15 | 2007-11-08 β Patent 8,293,700 granted on 2012-10-23Anti-bacterial composition especially for controlling gram-negative bacteria, comprising a peptide and an advantageously hydrophobic anti-bacterial agent
152909 β